233 Participants Needed

Quit Line Referral Support for Smoking

Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Wisconsin, Madison
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

The goal of this clinical trial is to understand how the Salvation Army staff can help people who use tobacco learn about and connect with no-cost treatments to help cut down or quit smoking. Researchers will gather information about the thoughts and experiences of people who smoke tobacco and receive services at the Salvation Army, as well as the experiences of the staff offering support to help treat tobacco use.

Do I need to stop taking my current medications to join the trial?

The trial information does not specify whether you need to stop taking your current medications. It focuses on helping people quit smoking, so it's best to ask the study team for more details.

Is the Quit Line Referral Support for Smoking safe for humans?

The research articles reviewed do not provide specific safety data for Quit Line Referral Support for Smoking or its related interventions. They focus on the effectiveness of financial incentives and referral methods for smoking cessation.12345

How is the Quit Line Referral Support for Smoking treatment different from other smoking cessation treatments?

This treatment is unique because it combines cognitive-motivational feedback, consumer incentives, and staff support to encourage immediate referral to a tobacco quit line, which is not commonly used in standard smoking cessation programs. The use of financial incentives and personalized feedback aims to enhance engagement and success rates among smokers, particularly those from low-income backgrounds.15678

What data supports the effectiveness of the treatment Cognitive-Motivational Feedback, Consumer Incentives for Immediate Referral to a Tobacco Quit Line, Staff Tobacco Quit Line Referral Implementation Support for smoking cessation?

Research shows that personalized feedback can double the rate of continuous smoking abstinence, and financial incentives can improve recruitment and cessation outcomes, especially among low-income smokers. These findings suggest that combining feedback and incentives can effectively support smoking cessation efforts.145910

Who Is on the Research Team?

DM

Danielle McCarthy, PhD

Principal Investigator

University of Wisconsin, Madison

Are You a Good Fit for This Trial?

This trial is for adults over 18 who are involved with the Salvation Army, either receiving or providing social services, and can communicate in English, Spanish, or another language with interpreter support. It's not open to children under 18 or those unable to speak a common language.

Inclusion Criteria

Involved in the management, delivery, or receipt of social services at a participating Salvation Army site, or a member of the University of Wisconsin-Center for Tobacco Research and Intervention Outreach Team supporting Wisconsin Tobacco Quit Line implementation

Exclusion Criteria

I cannot communicate in the same language as the study team or an available interpreter.
I am under 18 years old.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Implementation Planning

Planning and preparation for implementing strategies to connect consumers with the Wisconsin Tobacco Quit Line

3 months

Implementation

Pilot testing and refining enhanced implementation support and incentive strategies at Salvation Army sites

18 months
Ongoing support and training sessions

Follow-up

Participants are monitored for effectiveness of the implementation strategies and tobacco use outcomes

6 months

What Are the Treatments Tested in This Trial?

Interventions

  • Cognitive-Motivational Feedback
  • Consumer Incentives for Immediate Referral to a Tobacco Quit Line
  • Staff Tobacco Quit Line Referral Implementation Support
Trial Overview The study tests how effective different methods are at helping tobacco users quit. This includes cognitive-motivational feedback, staff training on referring people to a Tobacco Quit Line, and offering incentives for immediate referrals.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Group I: Incentivized Immediate Wisconsin Tobacco Quit Line (WTQL) ReferralExperimental Treatment3 Interventions
Group II: Enhanced Wisconsin Tobacco Quit Line (WTQL) Referral Implementation SupportExperimental Treatment2 Interventions

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Wisconsin, Madison

Lead Sponsor

Trials
1,249
Recruited
3,255,000+

National Institutes of Health (NIH)

Collaborator

Trials
2,896
Recruited
8,053,000+

National Cancer Institute (NCI)

Collaborator

Trials
14,080
Recruited
41,180,000+

Published Research Related to This Trial

A study involving 1,217 participants found that personalized feedback significantly improved smoking cessation rates, with continuous abstinence at 3 and 12 months being twice as high in the feedback group compared to others.
In contrast, while a financial incentive increased the use of self-help materials, it did not improve cessation rates and was linked to higher relapse rates among those who quit.
Evaluation of intrinsic and extrinsic motivation interventions with a self-help smoking cessation program.Curry, SJ., Wagner, EH., Grothaus, LC.[2019]
A study involving 5200 Medicaid smokers showed that financial incentives significantly increased re-engagement in quitline services, with a dose-response effect observed; higher incentives led to higher re-engagement rates.
Mailed letters were more effective than phone calls for re-engagement, and the likelihood of re-engaging decreased as time since initial enrollment increased, highlighting the importance of timely interventions for smokers.
Re-engagement of Low-Income Smokers in Quitline Services: Effects of Incentives and Method of Contact.Cummins, SE., Kirby, CA., Wong, S., et al.[2023]
In a study involving 35 smokers, those who were more dependent on nicotine (smoking within 5 minutes of waking) required a higher financial incentive to quit, highlighting the varying motivations among smokers.
The use of a willingness-to-accept (WTA) auction led to a 45% quit rate among participants who won the auction, compared to only 20% for those who did not win, suggesting that tailored financial incentives can significantly enhance smoking cessation success.
Going Once, Going Twice: Using Willingness-to-Accept Auctions to Promote Smoking Cessation.Quisenberry, AJ., Shaw, S., Ferketich, AK., et al.[2021]

Citations

Practice-based referrals to a tobacco cessation quit line: assessing the impact of comparative feedback vs general reminders. [2022]
Evaluation of intrinsic and extrinsic motivation interventions with a self-help smoking cessation program. [2019]
Re-engagement of Low-Income Smokers in Quitline Services: Effects of Incentives and Method of Contact. [2023]
A randomized controlled trial of financial incentives to low income pregnant women to engage in smoking cessation treatment: Effects on post-birth abstinence. [2019]
Give It Up For Baby: outcomes and factors influencing uptake of a pilot smoking cessation incentive scheme for pregnant women. [2021]
Effects of large financial incentives on motivation to quit smoking and on cigarette dependence. [2023]
Going Once, Going Twice: Using Willingness-to-Accept Auctions to Promote Smoking Cessation. [2021]
A randomized, controlled trial of adding expired carbon monoxide feedback to brief stop smoking advice: evaluation of cognitive and behavioral effects. [2022]
A randomized trial of a pay-for-performance program targeting clinician referral to a state tobacco quitline. [2022]
10.United Statespubmed.ncbi.nlm.nih.gov
Does offering more support calls to smokers influence quit success? [2015]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security